Jul 1 |
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
|
Jul 1 |
3 Magnificent Stocks Retirees Can Buy and Hold Forever
|
Jul 1 |
10 clinical trials to watch in the second half of 2024
|
Jun 29 |
How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
|
Jun 28 |
How Medicare drug price negotiations could hit pharma stocks
|
Jun 28 |
Coherus offloads Humira biosimilar Yusimry for $40m
|
Jun 28 |
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
|
Jun 28 |
AbbVie, Genmab blood cancer therapy endorsed in EU
|
Jun 28 |
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
|
Jun 28 |
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
|